Home > Cool Tech > Newly-developed nanotech sunscreen binds to your…

Newly-developed nanotech sunscreen binds to your skin, but doesn't seep in

Sunscreen is ideal for protecting your skin from the damaging UV rays of sunlight, but it is not perfect. The same chemicals that keep you safe from the sun also seep into your skin and enter your bloodstream. The risks of this exposure are unknown, but it is enough of concern that some people would rather burn their skin than coat their body with these chemicals. To address these concerns, Yale University dermatologist Michael Girardi is developing a new type of sunscreen that protects you from the sun while also staying on the surface of the skin, reports Scientific American.

The most commonly used sunscreen chemicals are organic molecules that pass through the skin and, according to select cell culture studies, may bind to internal hormone receptors. To prevent this absorption, Girardi used the common UV-absorbing chemical padimate 0 and coated it with a biodegradable nanoparticle polymer that sticks to the skin. The nanoparticle binds to proteins on skin cells and stays there. The resulting sunscreen isn’t absorbed, doesn’t wash off in the water, and is only removed when you wipe down with a towel.

RelatedSeagull drone ‘poops’ sunscreen on kids playing at the beach

In laboratory studies using mice, Girardi showed that the new nanoparticle sunscreen protected mice from the damaging UV light as well as padimate O by itself. Moving beyond mice, Girardi plans to test out the sunscreen on human subjects in a pilot study scheduled for this summer. The small scale study will establish the SPF of the nano-sunscreen by applying it to 25 test subjects at different concentrations.

Girardi hopes his product encourages more people to use sunscreen by minimizing their risk of chemical exposure, and his colleagues agree. “If you can minimize the risk of sunscreen entering the bloodstream, it’s probably a good thing,” said National Cancer Institute dermatologist Kenneth Kraemer to Scientific American. Kraemer isn’t involved directly in the study, but has been monitoring its progress.